Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial
Wissenschaftlicher Artikel
Authors
Kapp-Schwoerer, Silke
Weber, Daniela
Corbacioglu, Andrea
Gaidzik, I, Verena
Paschka, Peter
Institutions
UKU. Klinik für Innere Medizin IIIPublished in
Blood ; 136 (2020), 26. - S. 3041-3050. - ISSN 0006-4971. - eISSN 1528-0020